drugset / Trial / NCT05969327
Role of Vitamin D Therapy in Recovery From Early Neonatal Sepsis (Randomized Controlled Trial)
RandomizedFactorialDouble-blindTreatment
Summary
Neonatal sepsis is still a major cause of morbidity and mortality despite major advances in neonatal intensive care units. Early-onset sepsis (EOS) is an infection of the blood acquired vertically from the mother and manifests shortly after birth. The objective of this study is to assess the vitamin D status in neonates with Early onset sepsis (EOS) and evaluate the influence of different doses of vitamin D3 (800 IU/d versus 400 IU/d), in these infants.
Timeline
- Start
- 2018-08-14
- Primary completion
- 2022-09-06
- Completion
- 2022-12-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vitamin D | Other / unclassified | 400 iu | Oral |
| Subject | Vitamin D | Other / unclassified | 800 iu | Oral |
Indications
No indication recorded.